Brighter initiated activity on multiple fronts following the issue of CE marks for its lead product, Actiste. It acquired Nectarine Health, a Swedish healthtech start-up, to complement its other assisted care solutions acquisition, Camanio.
Brighter also entered into a strategic partnership with Accumbo, a digital healthcare provider, to support the visibility of Actiste in the Swedish market, one of Brighter’s target markets. Also, to support commercialisation activities in the near term, the company raised SEK191m
Valuation: SEK1,383m or SEK7.13 per basic share
Our total valuation has increased from SEK1,227m to SEK1,383m due to higher net cash, while on a per-share basis, the value fell from SEK13.14 to SEK7.13 due to a higher share count.
Link to research:
https://www.edisongroup.com/publication/expanding-further-into-assisted-care-solutions/26386
Aktuellt
SENASTE
